Management of individuals with diabetes at high risk for hypoglycemia: an endocrine society clinical practice guideline

AL McCall, DC Lieb, R Gianchandani… - The Journal of …, 2023 - academic.oup.com
Context Hypoglycemia in people with diabetes is common, especially in those taking
medications such as insulin and sulfonylureas (SU) that place them at higher risk …

Clinical use of continuous glucose monitoring in adults with type 2 diabetes

AL Carlson, DM Mullen… - Diabetes technology & …, 2017 - liebertpub.com
Background: Hemoglobin A1c is an excellent population health measure for the risk of
vascular complications in diabetes, while continuous glucose monitoring (CGM) is a tool to …

Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial

RW Beck, TD Riddlesworth, K Ruedy… - Annals of internal …, 2017 - acpjournals.org
Background: Continuous glucose monitoring (CGM), which studies have shown is beneficial
for adults with type 1 diabetes, has not been well-evaluated in those with type 2 diabetes …

Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 …

J Frias, J Chien, Q Zhang, E Chigutsa… - The Lancet Diabetes & …, 2023 - thelancet.com
Background The burden of daily basal insulins often causes hesitancy and delays in the
initiation of insulin therapy. Basal insulin Fc (BIF, insulin efsitora alfa), designed for once …

[HTML][HTML] Continuous glucose monitoring versus self-monitoring of blood glucose in type 2 diabetes mellitus: a systematic review with meta-analysis

RN Janapala, JS Jayaraj, N Fathima, T Kashif… - Cureus, 2019 - ncbi.nlm.nih.gov
Every eleventh adult has diabetes, and every third has prediabetes. Over 95% of diabetics
are of type 2. It is well established that diabetes doubles the risk of heart disease and stroke …

Type 2 diabetes and the use of real-time continuous glucose monitoring

MA Jackson, A Ahmann, VN Shah - Diabetes technology & …, 2021 - liebertpub.com
The role of continuous glucose monitoring (CGM) in type 1 diabetes (T1D) is well
established in improving glycemic control and reducing hypoglycemia. Type 2 diabetes …

Effects of dapagliflozin on 24-hour glycemic control in patients with type 2 diabetes: a randomized controlled trial

RR Henry, P Strange, R Zhou, J Pettus… - Diabetes technology …, 2018 - liebertpub.com
Abstract Background: Glycated hemoglobin (HbA1c) and measures of short-term glycemia
do not fully capture daily patterns in plasma glucose dynamics. This study evaluated 24-h …

The risks of nocturnal hypoglycaemia in insulin-treated diabetes

AJ Graveling, BM Frier - Diabetes research and clinical practice, 2017 - Elsevier
Over half of all episodes of severe hypoglycaemia (requiring external help) occur during
sleep, but nocturnal hypoglycaemia is often asymptomatic and unrecognised. The precise …

Вариабельность гликемии при сахарном диабете

ВВ Климонтов, НЕ Мякина - 2018 - elibrary.ru
Монография посвящена проблеме вариабельности гликемии при сахарном диабете.
Рассмотрены физиологические и патофизиологические основы флуктуаций уровня …

Prevention and management of severe hypoglycemia and hypoglycemia unawareness: incorporating sensor technology

P Lucidi, F Porcellati, GB Bolli, CG Fanelli - Current diabetes reports, 2018 - Springer
Abstract Purpose of Review In addition to assisting in achieving improved glucose control,
continuous glucose monitoring (CGM) sensor technology may also aid in detection and …